NCT03768063: A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
- State
- Under way
- Phase
- Phase 3
- People
- 1,000 planned
- Started
- 28 Feb 2019
- Primary completion
- 5 Jul 2028
- Arms
- Combined Agents with Atezolizumab
- Results
- None posted
- 7 Dec 2018: Trial registered
- 28 Feb 2019: Trial started